AI assistant
Sending…
IO Biotech, Inc. — Director's Dealing 2022
Mar 3, 2022
34883_dirs_2022-03-03_17be855a-81a5-4fb9-bcf9-4a48d43fa946.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: IO Biotech, Inc. (IOBT)
CIK: 0001865494
Period of Report: 2022-03-01
Reporting Person: Smith David V (N/A)
More from IO Biotech, Inc.
Board/Management Information
2026
Mar 31
Delisting Announcement
2026
Feb 13
Major Shareholding Notification
2026
Feb 13
Major Shareholding Notification
2026
Feb 6
Regulatory Filings
2026
Jan 30
Major Shareholding Notification
2026
Jan 23
Regulatory Filings
2026
Jan 21
Delisting Announcement
2025
Dec 19
Board/Management Information
2025
Nov 21
Investor Presentation
2025
Nov 18